|
In response to
"Chloroquine study shows no benefit, extra deaths from COVID-19 -- (link)"
by
Reagen
|
Would be nice if the article linked to the paper, but I managed to find it.
|
Crazy wide confidence intervals on those hazard ratios make it look rather underpowered. But I was glad to see them account for differing patient profiles between HC and non-HC patients by introducing a propensity score. My boss loves propensity scores.
|